Centre for Advanced Studies in Chemistry, North-Eastern Hill University, NEHU Permanent Campus, Umshing, Shillong 793 022, India; Sophisticated Analytical Instrument Facility, North-Eastern Hill University, NEHU Permanent Campus, Umshing, Shillong 793 022, India.
Centre for Advanced Studies in Chemistry, North-Eastern Hill University, NEHU Permanent Campus, Umshing, Shillong 793 022, India.
J Inorg Biochem. 2025 Jan;262:112750. doi: 10.1016/j.jinorgbio.2024.112750. Epub 2024 Sep 30.
Diorganotin complexes of the compositions [MeSn(L)] (1), [n-BuSn(L)] (2), [PhSn(L)]⋅CH (3), [BzSn(L)]⋅CH (4) and [n-OctSn(L)] (5) were synthesized by reacting RSnO (R = Me, n-Bu, Ph, Bz or n-Oct) with the N,N-di(thiazol-2-yl)pyridine-2,6-dicarboxamide (HL, where H denotes the two acidic protons) in refluxing toluene. Additionally, the mono-n-butyltin complex [n-BuSn(HL)Cl]·HO (6) was synthesized from n-BuSnCl and HL in acetonitrile. Compounds were characterized by FT-IR, H, C and Sn NMR spectroscopy, while their solid-state structures were examined using single-crystal X-ray diffraction studies. In diorganotin compounds 1-5, the dianionic tridentate ligands (N, N, N) act as κ-N chelators. In 6, the L moiety (O, N, N) acts as a κ-ON tridentate chelator, with involvement of one of the carboxamide oxygen atoms. The coordination polyhedron around the Sn(IV) ion is completed either by two axial Sn-R ligands in compounds 1-5 or by n-Bu and Cl ligands in compound 6, giving rise to distorted trigonal bipyramid or octahedral structures, respectively. The tin NMR results show that the penta-coordinated structures of compounds 1-5 and the hexacoordinated structure of compound 6, observed in the solid-state, are retained in solution. The in vitro antitumor activities of 1-5 were tested on T-47D breast cancer cells. Of these, diphenyltin compound 3 showed the highest anti-proliferative effect, with an IC of 10 ± 1.60 μM. Compound 3 exhibited selective toxicity, potentially inducing apoptosis via reactive oxygen species generation and nuclear changes, indicating promise as a breast cancer treatment. This study is the first to explore thiazole-appended organotin compounds for cytotoxicity.
[MeSn(L)](1)、[n-BuSn(L)](2)、[PhSn(L)]·CH(3)、[BzSn(L)]·CH(4)和[n-OctSn(L)](5)的二有机锡配合物是通过将 RSnO(R = Me、n-Bu、Ph、Bz 或 n-Oct)与 N,N-二(噻唑-2-基)吡啶-2,6-二羧酸酰胺(HL,其中 H 表示两个酸性质子)在回流甲苯中反应合成的。此外,还通过 n-BuSnCl 和 HL 在乙腈中合成了单正丁基锡配合物[n-BuSn(HL)Cl]·HO(6)。通过 FT-IR、H、C 和 Sn NMR 光谱对化合物进行了表征,而它们的固态结构则通过单晶 X 射线衍射研究进行了检查。在二有机锡化合物 1-5 中,二价阴离子三齿配体(N、N、N)作为κ-N 螯合剂。在 6 中,L 部分(O、N、N)作为κ-ON 三齿配体,涉及一个羧酰胺氧原子。Sn(IV)离子的配位多面体由化合物 1-5 中的两个轴向 Sn-R 配体或化合物 6 中的 n-Bu 和 Cl 配体完成,分别导致扭曲的三角双锥或八面体结构。锡 NMR 结果表明,在固态中观察到的化合物 1-5 的五配位结构和化合物 6 的六配位结构在溶液中保持不变。在 T-47D 乳腺癌细胞上测试了 1-5 的体外抗肿瘤活性。在这些化合物中,二苯基锡化合物 3 表现出最高的抗增殖作用,IC 为 10±1.60μM。化合物 3 表现出选择性毒性,可能通过活性氧物种的产生和核变化诱导细胞凋亡,表明有望作为乳腺癌治疗药物。这项研究是首次探索噻唑基有机锡化合物的细胞毒性。